TDOC the future of Healthcare? Cathie Wood`s biggest bet in telemedicine is Teladoc Health Inc.
She wants said Teladoc is the future of healthcare.
Now sitting at a strong support level. I expect a bounce from here!
52 Week Range 66.50 - 308.00
TDOC has a MARKET CAP of 11.931Bil.
At this discounted price it can be a buyout from AMZN or others.
Credit Suisse Group has a price target of $207.
Looking forward to read your opinion about it.
Telemedicine
PHGI:CSE - Premier Health Group: on watch for break outPHGI:CSE - Premier Health Group: on watch for break out! after a nice run in late 2019 early 2020 we have pulled back for a few weeks now, tagging both the 50dma and 200dma. It has now built a series of higher lows with a initial resistance at $0.435 creating an ascending wedge pattern. The 50dma is about to cross over the 200dma giving a bullish sign and with a move over $0.435 and $0.51 I'd watch for a move upwards to the $0.65 region.
The sector in which PHGI is in is quite new and budding, Telemedicine, where its possible to see the doctor without leaving your house or office! Plenty of room for growth, Premier health group is guiding ~20 million in revenue for 2020, it has a low public float and only 70 million shares issued, these variables could prove for a nice upward move towards $1.00 and beyond
SHG - Skylight Health Group Inc.Daily chart. Short shelf life so far on this play. Looking for this to hold channel and break current downtrend (white line). MACD still needs a it of work but its starting to curl, RSI looks great. Holding and adding to this play in this area of support. Sell signal if lower channel support fails.
CVLB Expects 2020 Revenue up 205% to Record $38.0 MillionConversion Labs Expects 2020 Revenue up 205% to Record $38.0 Million, Subscription ARR up 525% to $26.0 Million
preliminary unaudited results for its fourth quarter and full year ended December 31, 2020.
Revenue for the fourth quarter is expected to total $13.6 million, up 265% from $3.7 million in the fourth quarter of 2019. Revenue for the full year is expected to total $38.0 million, up 205% from $12.5 million in 2019.
We ended the year exceptionally strong, with December revenues hitting a monthly record of $5.1 million, up 321% over December of last year. In fact, December 2020 alone eclipsed the whole of the fourth quarter of 2019.”
ual recurring revenue (ARR) generated by subscriptions reached $26.0 million by the end of the year, up 525% compared to the end of 2019 (see description of ARR, below). ARR increased by more than $3.0 million from November to December—another record-setting monthly gain.
“Given our extensive telehealth platform buildout in 2019, we were prepared when the breakout of the COVID-19 pandemic suddenly accelerated the consumer shift from traditional healthcare to telemedicine,”
expect 2021 to be our biggest year yet.”
finance.yahoo.com
TDOC to rise and test the long term resistanceTDOC presents us with a good risk vs reward opportunity when taking into consideration both the fundamental and technical analysis. Fundamentally, Teledoc is a giant in the tele health sector and with the future moving towards online, It would not be surprising to see Teledoc trade at much higher prices in the near future. - HH
* This is not financial advice, just an opportunity we want to share.
AMWL over 29.16A recent IPO that seems to have bottomed following a poor reaction to earnings. A few ways to play this. Oversold, could move quickly up to the volume cluster at 28 and meet some resistance. Over past closes of 29.97 and the psych number of 30 is a more conservative entry. Or, a strong long term candidate in the telemedicine space.
Flag break, breakout to comeLVGO has been consolidating for a few weeks now showing a break of the flag after two weekly candles without a major breakout upwards. On the weekly you can see the PSAR flip to bullish which is a strong and reliable indicator. Short-term resistance is at 145.12 with a clear path above an ATH breakout of 150. Upcoming catalysts may include an update provided on the TDOC merger scheduled for Mon Oct. 9th or earnings in early November.
DOC.C - Telemedicine services in high demand during the pandemicCloudMD Reaches Over 100,000 Registered Users on Telemedicine Platform
VANCOUVER, British Columbia, April 07, 2020 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (CSE: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telemedicine company revolutionizing the delivery of healthcare to patients, is excited to announce that it has reached over 100,000 registered users combined on its CloudMD and MyHealthAccess telemedicine platforms. To date, CloudMD has grown its platform of registered users organically and a large part of its customer acquisition has come from referrals from its network of doctors in Canada. Patients on both platforms have easy access to the extended hours, 7 day week coverage provided by the CloudMD doctors.
Since its launch in February 2020, CloudMD has grown its platform by almost 10,000 app downloads. During the last two weeks, approximately 1000 virtual doctors appointments were booked on the CloudMD platform, growth of over 3x compared to the previous period. Combined registration on both platforms have also increased 133% over the last week, as more people remain in isolation and cannot attend in-person medical appointments.
With the recent COVID-19 pandemic, CloudMD offers Canadians an alternative to in-person visits to crowded or closed medical clinics. Patients can now download the CloudMD app and schedule a same day appointment online and connect directly with a licensed physician on their phone, tablet, or computer from the comfort of their home.
Dr. Essam Hamza, CEO of CloudMD commented, “CloudMD continues to revolutionize the way healthcare is delivered to patients. We are excited and encouraged by the continued growth of our CloudMD platform as the significant increase in registered users continues to reinforce buy-in from the communities we serve.” He continued, “During these difficult times we are proud to offer much needed and timely medical care to the Canadian population. We remain committed to providing the best health care services to our patients.”
CloudMD also announces it has engaged Strike Communication Inc. (“Strike”) to manage investor relations and corporate development strategies. Strike is a boutique capital markets advisory firm based in Vancouver, BC. As part of its compensation, Strike will be granted incentive stock options exercisable to purchase up to 150,000 common shares in the capital of the Company at an exercise price of $0.50 per share for a period of five years. 100% of the incentive stock options will vest 12 months after the grant.